These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 307740)

  • 41. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.
    Ball BD; Hill MR; Brenner M; Sanks R; Szefler SJ
    Ann Allergy; 1990 Jul; 65(1):37-45. PubMed ID: 2195921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone.
    Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ
    Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tongue necrosis disclosing Horton's disease. Role of an associated ergotism].
    Saveuse H; Rouveix E; Franc B; Foubert A; Lesur G; Dorra M
    Ann Med Interne (Paris); 1990; 141(7):635-7. PubMed ID: 2085250
    [No Abstract]   [Full Text] [Related]  

  • 45. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peripheral gangrene following iatrogenic ergotism].
    Pigrau Serrallach C; Llorens Forés A; Arnau de Bolós JM; Clotet Sala B; Pahissa Berga A
    Med Clin (Barc); 1981 Jun; 77(2):85-6. PubMed ID: 7321634
    [No Abstract]   [Full Text] [Related]  

  • 47. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
    Harris R; German D
    Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Venous insufficiency of the lower limbs. Report on 45 cases].
    Babilliot J; Escalier-Imbert M
    Phlebologie; 1977; 30(1):113-7. PubMed ID: 866432
    [No Abstract]   [Full Text] [Related]  

  • 49. [Jaundice and hepatic hemangioma after ten years of oral contraception and recent administration of triacetyloleandomycin].
    Meyniel D; Pieron R; Cotillon C; Huguet C; Lecomte D
    Therapie; 1980; 35(6):754-5. PubMed ID: 6972102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
    Lahnborg G
    Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of uptake of dihydroergotamine by isolated rat hepatocytes: effect of troleandomycin.
    Dumont M; de Couët G; Le Bigot JF; Erlinger S
    J Pharmacol Exp Ther; 1985 Jul; 234(1):239-43. PubMed ID: 3874283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New method of medicinal treatment of cardiospasm].
    Tikholov K
    Vutr Boles; 1982; 21(2):60-5. PubMed ID: 7101891
    [No Abstract]   [Full Text] [Related]  

  • 54. Triacetyl-oleandomycin in the treatment of upper and lower respiratory tract infections (report on a multicenter study).
    Van Cauwenberghe P
    Quad Antibiot; 1975 Jun; ():122-40. PubMed ID: 1088733
    [No Abstract]   [Full Text] [Related]  

  • 55. [A case of cholestatic jaundice due to tetracycline-triacetyloleandomycin].
    Ichida F; Watanabe K; Ishiwara S; Inoue K; Tanabe Y
    Nihon Naika Gakkai Zasshi; 1965 May; 54(2):142-7. PubMed ID: 5294320
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical studies on chewable triacetyloleandomycin].
    Kitamoto O; Fukaya K
    J Antibiot B; 1967 Dec; 20(6):410-4. PubMed ID: 5301338
    [No Abstract]   [Full Text] [Related]  

  • 57. Dihydroergotamine interaction with propranolol.
    Gandy W
    Ann Emerg Med; 1990 Feb; 19(2):221. PubMed ID: 2301806
    [No Abstract]   [Full Text] [Related]  

  • 58. [TREATMENT OF GONORRHEA WITH TRIACETYLOLEANDOMYCIN (TAO)].
    PRZYLIPIAK R; CHODYN E; LUKOWICZ M
    Pol Tyg Lek; 1963 Mar; 18():439-40. PubMed ID: 14049774
    [No Abstract]   [Full Text] [Related]  

  • 59. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 60. Dihydroergotamine extravasation: prolonged arterial vasospasm requiring medical and surgical treatment.
    Martin K; Fuller J; Shaker KA; Sharma K
    Clin Toxicol (Phila); 2023 Aug; 61(8):621-622. PubMed ID: 37655782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.